Back to Search
Start Over
Structure, activation and dysregulation of fibroblast growth factor receptor kinases: perspectives for clinical targeting.
- Source :
-
Biochemical Society transactions [Biochem Soc Trans] 2018 Dec 17; Vol. 46 (6), pp. 1753-1770. Date of Electronic Publication: 2018 Dec 13. - Publication Year :
- 2018
-
Abstract
- The receptor tyrosine kinase family of fibroblast growth factor receptors (FGFRs) play crucial roles in embryonic development, metabolism, tissue homeostasis and wound repair via stimulation of intracellular signalling cascades. As a consequence of FGFRs' influence on cell growth, proliferation and differentiation, FGFR signalling is frequently dysregulated in a host of human cancers, variously by means of overexpression, somatic point mutations and gene fusion events. Dysregulation of FGFRs is also the underlying cause of many developmental dysplasias such as hypochondroplasia and achondroplasia. Accordingly, FGFRs are attractive pharmaceutical targets, and multiple clinical trials are in progress for the treatment of various FGFR aberrations. To effectively target dysregulated receptors, a structural and mechanistic understanding of FGFR activation and regulation is required. Here, we review some of the key research findings from the last couple of decades and summarise the strategies being explored for therapeutic intervention.<br /> (© 2018 The Author(s).)
Details
- Language :
- English
- ISSN :
- 1470-8752
- Volume :
- 46
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Biochemical Society transactions
- Publication Type :
- Academic Journal
- Accession number :
- 30545934
- Full Text :
- https://doi.org/10.1042/BST20180004